Abstract
In these days of serious healthcare cost containment, there is considerable concern about the relationship between outcome and cost in critically ill patients with multiple organ failure. Even though a large number of these persons die and multiple organ failure is expensive to treat, an examination of the long-term outcomes and direct costs of treatment in specific groups of patients with multiple organ failure has demonstrated that this cost can be reasonable in terms of cost per life-year gained and even quality adjusted life-years gained. Dr David J Bihari discussed these issues at the 26th Educational and Scientific Symposium of the Society of Critical Care Medicine [ San Diego, California, February 1997 ].
Rights and permissions
About this article
Cite this article
Prescott, L. Multiorgan failure in the critically ill: outcomes and costs. Inpharma Wkly. 1076, 5–6 (1997). https://doi.org/10.2165/00128413-199710760-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199710760-00010